Untitled - The Canadian Association of Gastroenterology
Untitled - The Canadian Association of Gastroenterology
Untitled - The Canadian Association of Gastroenterology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
744 PRINCIPES FONDAMENTAUX DE GASTRO-ENTÉROLOGIE<br />
Section 11 Hépatopathie héréditaire<br />
Asberg A, Hveem K, Thorstensen K, Ellekjter E, et al. Screening for haemochromatosis:<br />
high prevalence and low morbidity in an unselected population <strong>of</strong> 65,238 persons.<br />
Scand J Gastroenterol 2001; 36:1108-1115.<br />
Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams PC. Noninvasive<br />
prediction <strong>of</strong> cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36:673-678.<br />
Beutler E, Felitti V, Koziol J, Ho N, Gelbart T. Penetrance <strong>of</strong> the 845G to A (C282Y) HFE<br />
hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211-218.<br />
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in<br />
patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.<br />
Gitlin JD. Wilson disease. <strong>Gastroenterology</strong> 2003; 125:1868-1877.<br />
Lomas DA, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies:<br />
pathobiology and prospects for therapy. J Clin Invest 2002; 110:1585-1590.<br />
Wojcik J, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history <strong>of</strong><br />
C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002; 16:297-302.<br />
Section 12 Cholestase<br />
Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic disease. J Hepatol 2000;<br />
32(Suppl. 1):129-140.<br />
Section 13 Cirrhose hépatique<br />
Abraldes JG, Dell-Era A, Bosch J. Medical management <strong>of</strong> variceal bleeding in<br />
patients with cirrhosis. Can J Gastroenterol 2004; 18:109-113.<br />
Moore KP, Wong F, Gines P, et al. <strong>The</strong> management <strong>of</strong> ascites in cirrhosis: report on the<br />
consensus conference <strong>of</strong> the Intenational Ascites Club. Hepatology 2003; 38:258-266.<br />
Stewart SF, Day CP. <strong>The</strong> management <strong>of</strong> alcoholic liver disease. J Hepatol 2003; 38<br />
(Suppl. 1):2-13.<br />
Section 14 Hypertension portale<br />
Bosch J, Abraldes JG. Management <strong>of</strong> gastrointestinal bleeding in patients with cirrhosis<br />
<strong>of</strong> the liver. Semin Hematol 2004; 41(Suppl. 1):8-12.<br />
Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric antral<br />
vascular ectasia (GAVE) syndrome. Gut 2001; 49:866-872.<br />
Comar KM, Sanyal AJ. Portal hypertensive bleeding. Gastroenterol Clin North Am<br />
2003; 32:1079-1105.<br />
D’Amico G. <strong>The</strong> role <strong>of</strong> vasoactive drugs in the treatment <strong>of</strong> oesophageal varices.<br />
Expert Opin Pharmacother 2004; 5:349-360.<br />
Ferguson JW, Tripathi D, Hayes PC. Review article: the management <strong>of</strong> acute variceal<br />
bleeding. Aliment Pharmacol <strong>The</strong>r 2003; 18:253-262.<br />
Hoeper MM, Krowka MJ, Srassburg CP. Portopulmonary hypertension and hepatopulmonary<br />
syndrome. Lancet 2004; 363:1461-1468.<br />
Krowka MJ. Hepatopulmonary syndromes. Gut 2000; 46:1-4.<br />
Liu H, Lee SS. Cardiopulmonary dysfunction in cirrhosis. J Gastroenterol Hepatol<br />
1999; 14:600-608.<br />
Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26:<br />
842-847.
Change language